Editorial introductions

Current Opinion in Allergy and Clinical Immunology was launched in 2001. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of allergy and clinical immunology are divided into 14 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue. SECTION EDITORS Susan M. TarloSusan M. TarloDr Susan M. Tarlo MB BS FRCP(C) is a Professor in the Department of Medicine and in the Dalla Lana School of Public Health at the University of Toronto, Canada. She is a respiratory physician at the University Health Network, Toronto Western Hospital, Canada and at the Gage Occupational and Environmental Health Unit and Centre of Research Excellence in Occupational Diseases of St Michael's Hospital in Toronto, Canada. Her main areas of clinical practice and research are in occupational and environmental lung diseases and allergic responses, especially occupational asthma. She initially graduated from medical school at London University, England, and underwent postgraduate training in England for four years before coming to Queen's University, Kingston, Ontario, Canada for a year as a fellow in allergy and clinical immunology, followed by a respiratory medicine residency for two years at McMaster University, Hamilton, Canada. She has been in Toronto as a staff physician at the Toronto General Hospital and then at Toronto Western Hospital as well as at the Gage Occupational and Environmental Health Unit since 1976 as well as holding academic positions at the University of Toronto since that time. Piero MaestrelliPiero MaestrelliDr Maestrelli, MD, completed his medical degree at University of Padova, Italy, and then specialised in occupational medicine and in pulmonology. He completed a two year post doctoral fellowship at the Institute of Occupational Medicine, University of Padova, and then a two year research fellowship at the Department of Allergy and Clinical Immunology of Cardiothoracic Institute, London, UK. Dr Maestrelli has written over 150 scientific papers and book chapters, and has lectured nationally and internationally. He has been Chairman of the Interest Group on Occupational Allergy of European Academy of Allergology and Clinical Immunology for three years. He is currently Professor of Occupational Medicine at University of Padova, Department of Cardiologic, Thoracic and Vascular Sciences, Italy, and Director of the Unit of Occupational Medicine at the University Hospital of Padova. Leonard B. BacharierLeonard B. BacharierDr Bacharier is Professor of Pediatrics and Medicine at Washington University School of Medicine, USA and Clinical Director of the Division of Pediatric Allergy, Immunology and Pulmonary Medicine, and Unit co-Leader for the Pediatric Patient Orientated Research Unit. He received his undergraduate degree in biophysics from The Johns Hopkins University, USA and his medical degree from Washington University School of Medicine. Dr Bacharier was an intern and resident in pediatrics at St. Louis Children's Hospital and a fellow in pediatric allergy and immunology at Children's Hospital, Boston and Harvard Medical School, USA. He was a recipient of the 2005 Samuel R. Goldstein Leadership Award in Medical Student Education from Washington University School of Medicine and is a member of several organizations including the American Academy of Allergy, Asthma and Immunology and the American Thoracic Society. Dr Bacharier's research focuses on childhood asthma. Specifically, he is a Principal Investigator in the NHLBI-funded AsthmaNet, a multi-centered network examining therapeutic approaches to childhood asthma. He is an Investigator in the NHLBI's Severe Asthma Research Program (SARP) and the Inner City Asthma Consortium's URECA study examining the influence of urban environments on the development of asthma and allergic disorders. He is also an investigator in the American Lung Association's Asthma Clinical Research Center Network. Dr Bacharier is also currently investigating the role of early infection with Respiratory Syncytial Virus upon the subsequent development of asthma. These research projects have been published in numerous journals, including the New England Journal of Medicine, The Journal of Allergy and Clinical Immunology, Pediatrics, and The American Journal of Respiratory and Critical Care Medicine. Dr Bacharier serves on the Editorial Boards of The Journal of Allergy and Clinical Immunology and The Journal of Allergy and Clinical Immunology: In Practice, and has been a guest Editor for Immunology and Allergy Clinics of North America. Stanley J. SzeflerStanley J. SzeflerDr Szefler's major contributions are directed toward the individualized use of asthma therapy. He has identified biomarkers and asthma characteristics that are associated with asthma exacerbations and response to asthma therapy. He is currently the Research Medical Director and Director of the Pediatric Asthma Research Program in the Breathing Institute of the Pediatric Pulmonary Section at Children's Hospital Colorado. He is also Professor of Pediatrics at the University of Colorado Denver School of Medicine. Since 1997, he has been the Deputy Editor for the Journal of Allergy and Clinical Immunology. He is a member of the Global Initiative for Asthma Science Committee and Board of Directors. He has been a member of the Expert Panel for the National Heart, Lung, and Blood Institute's National Asthma Education and Prevention Program on “Guidelines for the Diagnosis and Management of Asthma”. He is also the Principal Investigator for the Denver site of the NHLBI AsthmaNet-Pediatrics Section. For the past ten years, he has developed a school-centered asthma program funded by the Colorado Department of Public Health and Environment Cancer, Cardiovascular and Pulmonary Disease Program and Glaxo SmithKline. This program identifies those students most significantly affected by asthma and establishes lines of communication between schools, primary care physicians, and specialists to assure that these children have consistent medical care.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.